Form 6-K ARGENX SE For: Sep 30

Go back to Form 6-K ARGENX SE For: Sep 30

argenx SE (ARGX) PT Raised to $635 at Leerink Partners

November 1, 2024 7:22 AM EDT

Leerink Partners analyst Thomas J. Smith raised the price target on argenx SE (NASDAQ: ARGX) to $635.00 (from $550.00) while maintaining a Outperform rating.

The analyst comments "Bottom Line: ARGX (OP) reported yet another strong quarter of Vyvgart sales, beating consensus expectations for the 11th consecutive quarter (see our quick take HERE). Notably, this marked the first full quarter of Vyvgart Hytrulo sales in CIDP, and... More

Raymond James Reiterates Strong Buy Rating on argenx SE (ARGX)

October 31, 2024 1:15 PM EDT

Raymond James analyst Danielle Brill reiterated an Strong Buy rating on argenx SE (NASDAQ: ARGX).

The analyst comments "3Q24 Vyvgart revenues of $573M (+20% q/q) swiftly beat our $513M and consensus $520M estimates. Growth momentum remains strong in the gMG segment and... More